Interleukin‐6 and the Risk of Adverse Outcomes in Patients After an Acute Coronary Syndrome: Observations From the SOLID‐TIMI 52 (Stabilization of Plaque Using Darapladib—Thrombolysis in Myocardial Infarction 52) Trial-Reference-Cited by-同舟云学术

Interleukin‐6 and the Risk of Adverse Outcomes in Patients After an Acute Coronary Syndrome: Observations From the SOLID‐TIMI 52 (Stabilization of Plaque Using Darapladib—Thrombolysis in Myocardial Infarction 52) Trial

Published:2017-10-11 Issue:10 Volume:6 Page:
ISSN:2047-9980
Container-title:Journal of the American Heart Association
language:en
Short-container-title:JAHA

Author:

Fanola Christina L.¹,Morrow David A.¹,Cannon Christopher P.¹,Jarolim Petr²,Lukas Mary Ann³,Bode Christoph⁴,Hochman Judith S.⁵,Goodrich Erica L.¹,Braunwald Eugene¹,O'Donoghue Michelle L.¹

Affiliation:

1. TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA

2. Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA

3. Metabolic Pathways and Cardiovascular Therapeutic Area, GlaxoSmithKline, Philadelphia, PA

4. Cardiology and Angiology I, University Heart Center Freiburg, Freiburg, Germany

5. Division of Cardiology, Department of Medicine, New York University School of Medicine, New York, NY

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference29 articles.

1. Progress and challenges in translating the biology of atherosclerosis

2. Interleukin-6 and the acute phase response

3. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?

4. Impact of Interleukin-6 on Plaque Development and Morphology in Experimental Atherosclerosis

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. La phospholipase A2 associée aux lipoprotéines (Lp-PLA2) : biomarqueur pertinent et cible thérapeutique ?;Annales Pharmaceutiques Françaises;2024-09

2. The association of inflammatory biomarkers and long-term clinical outcomes in older adults with non-ST elevation acute coronary syndrome;International Journal of Cardiology;2024-08

3. Differential circulating cytokine profiles in acute coronary syndrome versus stable coronary artery disease;Scientific Reports;2024-07-27

4. Effect of Serum IL-6 Levels on the Progression of Non-Target Lesions in Patients after Coronary Stenting;Reviews in Cardiovascular Medicine;2024-06-27

5. Challenges and advances in the management of inflammation in atherosclerosis;Journal of Advanced Research;2024-06